Sugi Predict

Sugi Predict / Compounds / SCHEMBL806737

SCHEMBL806737

SCHEMBL806737

CC(C)=CCC/C(C)=C/CC(=O)O

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ FNTA P49354 5/20 0.66
▸ FNTB P49356 5/20 0.66
▸ KDM4E B2RXH2 1/20 0.61
▸ ATM Q13315 1/20 0.61
▸ KMT2A Q03164 4/20 0.60
▸ POLB P06746 1/20 0.59
▸ MEN1 O00255 3/20 0.58
▸ MAPT P10636 3/20 0.58
▸ TRPA1 O75762 1/20 0.58
▸ ALOX15 P16050 3/20 0.56
▸ CYP3A4 P08684 2/20 0.56
▸ ALDH1A1 P00352 3/20 0.55
▸ UGT1A1 P22309 1/20 0.54
▸ SQLE Q14534 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1409916 1.00 FNTA (0.66) FNTAFNTBKDM4EATMKMT2A
SCHEMBL5361163 1.00 FNTA (0.66) FNTAFNTBKDM4EATMKMT2A
SCHEMBL11619480 0.98 FNTA (0.69) FNTAFNTBKDM4EATMKMT2A
SCHEMBL8758581 0.98 FNTA (0.69) FNTAFNTBKDM4EATMKMT2A
SCHEMBL15315193 0.98 FNTA (0.69) FNTAFNTBKDM4EATMKMT2A
SCHEMBL1105228 0.98 FNTA (0.69) FNTAFNTBKDM4EATMKMT2A
SCHEMBL11619483 0.98 FNTA (0.69) FNTAFNTBKDM4EATMKMT2A
SCHEMBL2921177 0.98 FNTA (0.69) FNTAFNTBKDM4EATMKMT2A
SCHEMBL28603272 0.92 FNTA (0.63) FNTAFNTBKDM4EATMKMT2A
SCHEMBL29833553 0.85 ALDH1A1 (0.54) FNTAFNTBKDM4EATMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7015247-B2 Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin analogs GUTTAG ALVIN 2006-03-21 — — US claimed
US-20030008833-A1 Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin analogs GUTTAG ALVIN (US) 2003-01-09 — — US claimed
US-20020065254-A1 Ibuprofen-aspirin and hydroxymethylacylfulvene analogs GUTTAG ALVIN (US) 2002-05-30 — — US claimed
US-4254291-A FORMING METAL ESTERS OR ALCOHOLATES, ISOMERIZATION AND HYDROLYSIS USING A TRANSITION METAL COMPOUND CATALYST SCM CORPORATION (US) 1981-03-03 — — US claimed
JP-61053261-A — — None — — JP disclosed
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION FIRMENICH & CIE (CH) 2026-03-12 — — US disclosed
US-20250368599-A1 PROCESS FOR THE PREPARATION OF CYCLOHOMOGERANATES BASF SE (DE) 2025-12-04 — — US disclosed
US-20250368599-A1 PROCESS FOR THE PREPARATION OF CYCLOHOMOGERANATES BASF SE (DE) 2025-12-04 — — US disclosed
US-20250368600-A1 USE OF CYCLOHOMOGERANATE ESTERS AS AROMA CHEMICALS BASF SE (DE) 2025-12-04 — — US disclosed
EP-4543845-A1 PROCESS FOR THE PREPARATION OF CYCLOHOMOGERANATES BASF SE (DE) 2025-04-30 — — EP disclosed
EP-4543845-A1 PROCESS FOR THE PREPARATION OF CYCLOHOMOGERANATES BASF SE (DE) 2025-04-30 — — EP disclosed
CN-119403780-A Process for preparing cyclohomofragrant folic acid ester 巴斯夫欧洲公司 2025-02-07 — — CN disclosed
EP-0403945-A2 Cycloaliphatic carbinols and their use as starting materials for the preparation of furan derivatives FIRMENICH SA (CH) 1990-12-27 — — EP disclosed
EP-0332143-A1 11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] KURARAY CO., LTD. (JP) 1989-09-13 — — EP disclosed
US-4693849-A Preparation of unsaturated compounds RHONE-POULENC SANTE (FR) 1987-09-15 — — US disclosed
US-4615838-A Unsaturated compounds and their preparation RHONE-POULENC SANTE (FR) 1986-10-07 — — US disclosed
US-4585594-A CARBONYLATION OF ALLYL ALCOHOL DERIVATIVE BASF AKTIENGESELLSCHAFT (DE) 1986-04-29 — — US disclosed
JP-S6153261-A BRANCHED-CHAIN SULFUR-CONTAINING COMPOUND JAPAN TOBACCO INC 1986-03-17 — — JP disclosed
US-4137273-A INSECTICIDES, CHEMICAL INTERMEDIATES ZOECON CORPORATION (US) 1979-01-30 — — US disclosed
US-4116955-A META-CYCLOPHANE AND A TRANS-TERPENOID, SEPARATION OF ISOMERS TEIJIN LIMITED (JP) 1978-09-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION CNOT9, MSL1, MT-CO2 FNTA 1933/4885FNTB 2074/4885KDM4E 1705/4885
US-20250368599-A1 PROCESS FOR THE PREPARATION OF CYCLOHOMOGERANATES GGPS1, FDPS, DHPS FNTA 5/4885FNTB 28/4885KDM4E 1697/4885
US-20020065254-A1 Ibuprofen-aspirin and hydroxymethylacylfulvene analogs PTGES3, HPGDS, PTGES FNTA 1248/4885FNTB 3061/4885KDM4E 653/4885
US-20030008833-A1 Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin analogs GALE, TPT1, HPSE FNTA 1214/4885FNTB 2716/4885KDM4E 1066/4885
US-20250368600-A1 USE OF CYCLOHOMOGERANATE ESTERS AS AROMA CHEMICALS DECR1, TECR, AKR1C2 FNTA 101/4885FNTB 315/4885KDM4E 568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.